Professor Carlos Alberto Parra López is the leader of a team of Colombian scientists who have been working for 12 years in the search for an effective treatment against the deadliest type of breast cancer in the world: triple negative breast cancer. Dr. Parra and his colleagues from the Immunology and Translational Medicine Research Group of the National University, in Bogotá, have created a vaccine from the tumor tissues of each patient. “The vaccines we are making for immunotherapy are personalized 100%,” explains Parra. The novel treatment, which in the near future may be a real alternative to improve the quality of life of patients and avoid severe relapses, is being applied to five women with serious diagnoses. The medical community awaits the results of the clinical trial with hope.
